Medifast (MED) Earnings Date, Estimates & Call Transcripts

$18.51

-0.68 (-3.54%)

(As of 09/6/2024 ET)

Upcoming Earnings Date: Nov. 4Estimated
Actual EPS (Aug. 5): $0.92 Beat By $0.56
Consensus EPS (Aug. 5): $0.36

MED Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MED Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Weiss Ratings

“Fed Proof” Your Bank Account with THESE 4 Simple Steps

Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.

Learn these 4 simple steps and protect your savings before it’s too late.

Medifast Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate	Company Guidance
Q1 2024	2	$0.82	$1.72	$1.27	0.250 - 0.950
Q2 2024	2	$0.32	$0.40	$0.36	0.050 - 0.400
Q3 2024	2	($0.15)	$0.13	($0.01)	- 0.700 - - 0.050
Q4 2024	1	$0.16	$0.16	$0.16
FY 2024	7	$1.15	$2.41	$1.78
Q1 2025	1	$0.35	$0.35	$0.35
Q2 2025	1	$0.37	$0.37	$0.37
Q3 2025	1	$0.39	$0.39	$0.39
Q4 2025	1	$0.43	$0.43	$0.43
FY 2025	4	$1.54	$1.54	$1.54
Q1 2026	1	$0.48	$0.48	$0.48
Q2 2026	1	$0.50	$0.50	$0.50

MED Earnings Date and Information

Medifast last posted its earnings results on August 5th, 2024. The specialty retailer reported $0.92 EPS for the quarter, beating the consensus estimate of $0.36 by $0.56. The business earned $168.56 million during the quarter, compared to analyst estimates of $160.44 million. Medifast has generated $6.20 earnings per share over the last year ($6.20 diluted earnings per share) and currently has a price-to-earnings ratio of 3.0. Earnings for Medifast are expected to decrease by -9.77% in the coming year, from $1.33 to $1.20 per share. Medifast has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based off prior year's report dates.

Medifast Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
11/4/2024 (Estimated)	-	-	-	-	-	-	-
8/5/2024	Q2 2024	$0.36	$0.92	+$0.56	$2.59	$160.44 million	$168.56 million
4/29/2024	Q1 2024	$0.78	$0.66	($0.12)	$0.56	$168.90 million	$174.74 million
2/20/2024	Q4 2023	$0.99	$1.09	+$0.10	$1.63	$184.17 million	$191.02 million
11/6/2023	Q3 2023	$1.02	$2.12	+$1.10	$2.12	$232.10 million	$235.87 million
8/7/2023	Q2 2023	$1.44	$2.77	+$1.33	$2.77	$270.20 million	$296.20 million
5/1/2023	Q1 2023	$2.40	$3.67	+$1.27	$3.67	$319.50 million	$349.00 million
Get the Latest News and Ratings for MED and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Medifast and its competitors with MarketBeat's FREE daily newsletter.
2/21/2023	Q4 2022	$2.18	$3.70	+$1.52	$4.99	$306.70 million	$337.25 million
11/3/2022	Q3 2022	$1.91	$3.32	+$1.41	$3.37	-	$390.40 million
8/3/2022	Q2 2022	$3.28	$3.87	+$0.59	$4.32	$462.60 million	$453.33 million
5/2/2022	Q1 2022	$3.56	$3.59	+$0.03	$3.59	$415.20 million	$417.60 million
2/23/2022	Q4 2021	$2.67	$2.91	+$0.24	$2.91	$375.79 million	$377.80 million
11/4/2021	Q3 2021	$2.92	$3.56	+$0.64	$3.56	$402.80 million	$413.40 million
8/4/2021	Q2 2021	$3.30	$3.96	+$0.66	$3.96	$359.25 million	$394.20 million
5/4/2021	Q1 2021	$2.72	$3.46	+$0.74	$3.46	$279.12 million	$340.70 million
2/25/2021	Q4 2020	$2.36	$2.36	-	$2.36	$246.67 million	$264.91 million
11/2/2020	Q3 2020	$2.49	$2.91	+$0.42	$2.91	$242.50 million	$271.40 million
8/5/2020	Q2 2020	$1.84	$1.9550	+$0.1150	$2.06	$194.75 million	$220.00 million
5/5/2020	Q1 2020	$1.33	$1.93	+$0.60	$2.30	$161.90 million	$178.46 million
2/26/2020	Q4 2019	$1.07	$1.66	+$0.59	$0.72	$162.00 million	$170.63 million
11/7/2019	Q3 2019	$1.33	$1.32	($0.01)	$1.32	$194.70 million	$190.10 million

Medifast Earnings - Frequently Asked Questions

When is Medifast's earnings date?: Medifast has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based off last year's report dates. Learn more on MED's earnings history.
What guidance has Medifast issued on next quarter's earnings?: Medifast issued an update on its third quarter 2024 earnings guidance on Monday, August, 5th. The company provided earnings per share guidance of -0.700--0.050 for the period, compared to the consensus earnings per share estimate of -0.520. The company issued revenue guidance of $125.0 million-$145.0 million, compared to the consensus revenue estimate of $161.8 million.
Did Medifast beat their earnings estimates last quarter?: In the previous quarter, Medifast (NYSE:MED) reported $0.92 earnings per share (EPS) to beat the analysts' consensus estimate of $0.36 by $0.56. Learn more on analysts' earnings estimate vs. MED's actual earnings.
How can I listen to Medifast's earnings conference call?: The conference call for Medifast's latest earnings report can be listened to online. Listen to Conference Call
How can I read Medifast's conference call transcript?: The conference call transcript for Medifast's latest earnings report can be read online. Read Transcript
How much revenue does Medifast generate each year?: Medifast (NYSE:MED) has a recorded annual revenue of $770.18 million.
How much profit does Medifast generate each year?: Medifast (NYSE:MED) has a recorded net income of $99.42 million. MED has generated $6.20 earnings per share over the last four quarters.
What is Medifast's price-to-earnings ratio?: Medifast (NYSE:MED) has a trailing price-to-earnings ratio of 2.99 and a forward price-to-earnings ratio of 13.92.
What is Medifast's EPS forecast for next year?: Medifast's earnings are expected to decrease from $1.33 per share to $1.20 per share in the next year, which is a -9.77% change.